מרכז המדיה

Meitar represented International Three Crown Petroleum and Israel Petroleum Company, private oil and gas exploration and exploitation companies, before the Supreme Court and the newly-established Economic Division of the Tel-Aviv District Court (in its first decision ever). Both courts accepted Meitar’s arguments and rejected the motion of Bontan Corporation (OTC: BNTNF) for a temporary injection aimed to prevent a transaction with an Israeli public shell company.

TEOCO, a Delaware private company that provides software solutions to telecom operators acquired TTI, an Israeli public company traded on NASDAQ, through a reverse triangular merger effected under Israeli law.

Meitar represented Amdocs in its acquisition of French based company Streamezzo SA for $41 million. The transaction was accomplished by way of a purchase of shares from Streamezzo’s shareholders and applying a forced-sale mechanism (bring along).

Meitar’s litigation group obtained a seminal decision from the Tel-Aviv District Court on behalf of Sella Capital (TASE: SLARL), an Israeli real estate investment trust (REIT), blocking a hostile takeover attempt commenced in the form of a scheme of arrangement. The District Court ruled in favor of Sella, holding that a scheme of arrangement requires the consent of the company board of directors, and therefore can not be used for hostile takeovers.

In March 2010, MX Telecom was acquired by Amdocs, an NYSE traded company which is a leading global provider of billing solutions. MX Telecom is a global aggregator providing connectivity and infrastructure, and facilitating payment and digital content delivery, to enable businesses to take advantage of mobile technology.

Emblaze, is an LSE traded Israeli company that operates in the mobile technology market and that held a controlling stake in Formula Systems, an Israeli public company that controls a number of public companies traded on NASDAQ and the TASE that provide various IT solutions. Asseco is a Polish company traded on the Warsaw stock exchange that operates various IT solutions companies in Eastern Europe.

Meitar’s litigation group successfully represented the India-based Sun Pharmaceuticals (NSE: SUNPHARMA; BSE: 524715) in its legal proceedings against Israel-based Taro Pharmaceutical Industries (PINK: TAROF). The Supreme Court accepted Sun’s argument that under Israel’s Companies Law Sun is exempt from commencing a special tender offer in order to gain control over Taro.